Literature DB >> 30541858

Splicing-Dependent Subcellular Targeting of Borna Disease Virus Nucleoprotein Isoforms.

Shohei Kojima1,2, Ryo Sato3, Mako Yanai1,2, Yumiko Komatsu1,4, Masayuki Horie1,5, Manabu Igarashi6, Keizo Tomonaga7,2,8.   

Abstract

Targeting of viral proteins to specific subcellular compartments is a fundamental step for viruses to achieve successful replication in infected cells. Borna disease virus 1 (BoDV-1), a nonsegmented, negative-strand RNA virus, uniquely replicates and persists in the cell nucleus. Here, it is demonstrated that BoDV nucleoprotein (N) transcripts undergo mRNA splicing to generate truncated isoforms. In combination with alternative usage of translation initiation sites, the N gene potentially expresses at least six different isoforms, which exhibit diverse intracellular localizations, including the nucleoplasm, cytoplasm, and endoplasmic reticulum (ER), as well as intranuclear viral replication sites. Interestingly, the ER-targeting signal peptide in N is exposed by removing the intron by mRNA splicing. Furthermore, the spliced isoforms inhibit viral polymerase activity. Consistently, recombinant BoDVs lacking the N-splicing signals acquire the ability to replicate faster than wild-type virus in cultured cells, suggesting that N isoforms created by mRNA splicing negatively regulate BoDV replication. These results provided not only the mechanism of how mRNA splicing generates viral proteins that have distinct functions but also a novel strategy for replication control of RNA viruses using isoforms with different subcellular localizations.IMPORTANCE Borna disease virus (BoDV) is a highly neurotropic RNA virus that belongs to the orthobornavirus genus. A zoonotic orthobornavirus that is genetically related to BoDV has recently been identified in squirrels, thus increasing the importance of understanding the replication and pathogenesis of orthobornaviruses. BoDV replicates in the nucleus and uses alternative mRNA splicing to express viral proteins. However, it is unknown whether the virus uses splicing to create protein isoforms with different functions. The present study demonstrated that the nucleoprotein transcript undergoes splicing and produces four new isoforms in coordination with alternative usage of translation initiation codons. The spliced isoforms showed a distinct intracellular localization, including in the endoplasmic reticulum, and recombinant viruses lacking the splicing signals replicated more efficiently than the wild type. The results provided not only a new regulation of BoDV replication but also insights into how RNA viruses produce protein isoforms from small genomes.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Mononegaviraleszzm321990; RNA splicing; bornavirus

Mesh:

Substances:

Year:  2019        PMID: 30541858      PMCID: PMC6384089          DOI: 10.1128/JVI.01621-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Generation of a non-transmissive Borna disease virus vector lacking both matrix and glycoprotein genes.

Authors:  Kan Fujino; Yusuke Yamamoto; Takuji Daito; Akiko Makino; Tomoyuki Honda; Keizo Tomonaga
Journal:  Microbiol Immunol       Date:  2017-09       Impact factor: 1.955

2.  Heat stress is a potent stimulus for enhancing rescue efficiency of recombinant Borna disease virus.

Authors:  Shohei Kojima; Tomoyuki Honda; Yusuke Matsumoto; Keizo Tomonaga
Journal:  Microbiol Immunol       Date:  2014-11       Impact factor: 1.955

3.  A methionine-rich domain mediates CRM1-dependent nuclear export activity of Borna disease virus phosphoprotein.

Authors:  Hideyuki Yanai; Takeshi Kobayashi; Yohei Hayashi; Yohei Watanabe; Naohiro Ohtaki; Guoqi Zhang; Juan Carlos de la Torre; Kazuyoshi Ikuta; Keizo Tomonaga
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Characterization of the major nuclear localization signal of the Borna disease virus phosphoprotein.

Authors:  M Schwemmle; C Jehle; T Shoemaker; W I Lipkin
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

5.  Genomic organization of Borna disease virus.

Authors:  T Briese; A Schneemann; A J Lewis; Y S Park; S Kim; H Ludwig; W I Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  RNA splicing in Borna disease virus, a nonsegmented, negative-strand RNA virus.

Authors:  P A Schneider; A Schneemann; W I Lipkin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  Endogenous non-retroviral RNA virus elements in mammalian genomes.

Authors:  Masayuki Horie; Tomoyuki Honda; Yoshiyuki Suzuki; Yuki Kobayashi; Takuji Daito; Tatsuo Oshida; Kazuyoshi Ikuta; Patric Jern; Takashi Gojobori; John M Coffin; Keizo Tomonaga
Journal:  Nature       Date:  2010-01-07       Impact factor: 49.962

8.  ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB.

Authors:  James A Maier; Carmenza Martinez; Koushik Kasavajhala; Lauren Wickstrom; Kevin E Hauser; Carlos Simmerling
Journal:  J Chem Theory Comput       Date:  2015-07-23       Impact factor: 6.006

9.  Identification of RNA instability elements in Borna disease virus.

Authors:  Ulrike Siemetzki; Mundrigi S Ashok; Thomas Briese; W Ian Lipkin
Journal:  Virus Res       Date:  2009-04-05       Impact factor: 3.303

Review 10.  Influenza A Virus M2 Protein: Roles from Ingress to Egress.

Authors:  Rashid Manzoor; Manabu Igarashi; Ayato Takada
Journal:  Int J Mol Sci       Date:  2017-12-07       Impact factor: 5.923

View more
  2 in total

1.  Optimal Expression of the Envelope Glycoprotein of Orthobornaviruses Determines the Production of Mature Virus Particles.

Authors:  Madoka Sakai; Yoko Fujita; Ryo Komorizono; Takehiro Kanda; Yumiko Komatsu; Takeshi Noda; Keizo Tomonaga; Akiko Makino
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

2.  The Borna Disease Virus 2 (BoDV-2) Nucleoprotein Is a Conspecific Protein That Enhances BoDV-1 RNA-Dependent RNA Polymerase Activity.

Authors:  Takehiro Kanda; Masayuki Horie; Yumiko Komatsu; Keizo Tomonaga
Journal:  J Virol       Date:  2021-08-18       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.